Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study

Abstract Aim The objective of this study was to investigate the level of soluble suppression of tumorigenicity-2 (sST2) in patients with acute ST-segment elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI), and to provide a new biomarker for clinical ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Shan Huang, Lu-Jiao Yu, Guang-Feng Sun, Zi-Xin Zhang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-025-04488-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594993064181760
author Shan Huang
Lu-Jiao Yu
Guang-Feng Sun
Zi-Xin Zhang
author_facet Shan Huang
Lu-Jiao Yu
Guang-Feng Sun
Zi-Xin Zhang
author_sort Shan Huang
collection DOAJ
description Abstract Aim The objective of this study was to investigate the level of soluble suppression of tumorigenicity-2 (sST2) in patients with acute ST-segment elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI), and to provide a new biomarker for clinical management and prognosis assessment. Method This was a prospective study. 148 STEMI patients following primary PCI were enrolled and divided into 2 groups by the median value of sST2 and afterwards followed up for 30 days to access the occurrence of major adverse cardiac events (MACEs), which were defined as cardiovascular death, heart failure and recurrent MI. Results sST2 ranged from 20.57 to 98.96 ng/mL. High sST2 group had higher MACEs rate compared to low sST2 group (28.8% vs. 8.0%, P = 0.001). sST2 was positively correlated with age (r = 0.181, P = 0.027), SYNTAX score (r = 0.257, P = 0.002), high-sensitive C-reactive protein (hs-CRP) (r = 0.225, P = 0.006), B-type natriuretic peptide (BNP) (r = 0.225, P = 0.006) and negatively with left ventricle ejection fraction (LVEF) (r = -0.197, P = 0.016). After adjustment for clinical variables, sST2 level (OR 3.680, P = 0.015) and LVEF (OR 0.880, P < 0.001) remained independent predictors of 30-days MACEs. In receiver operating characteristic curve (ROC) analyses, the area under the curve (AUC) of sST2 for predicting 30-days MACEs was 0.755(P < 0.001). The AUC of sST2 combining hs-CRP and LVEF for prediction was 0.828(95%CI [0.743–0.912], P < 0.001). Conclusion sST2 level after primary PCI was an independent risk factor of MACEs in STEMI patients through 30 days follow-up.
format Article
id doaj-art-9e5f940d80bf4b4dbe7897616b19da26
institution Kabale University
issn 1471-2261
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj-art-9e5f940d80bf4b4dbe7897616b19da262025-01-19T12:09:23ZengBMCBMC Cardiovascular Disorders1471-22612025-01-012511810.1186/s12872-025-04488-zShort-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational studyShan Huang0Lu-Jiao Yu1Guang-Feng Sun2Zi-Xin Zhang3Department of Cardiology, School of Medicine, Xiamen Cardiovascular Hospital of Xiamen University, Xiamen UniversityDepartment of Geriatrics, the First Hospital of China Medical UniversityDepartment of Emergency, School of Medicine, Xiamen Cardiovascular Hospital of Xiamen University, Xiamen UniversityDepartment of Cardiology, the First Hospital of China Medical UniversityAbstract Aim The objective of this study was to investigate the level of soluble suppression of tumorigenicity-2 (sST2) in patients with acute ST-segment elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI), and to provide a new biomarker for clinical management and prognosis assessment. Method This was a prospective study. 148 STEMI patients following primary PCI were enrolled and divided into 2 groups by the median value of sST2 and afterwards followed up for 30 days to access the occurrence of major adverse cardiac events (MACEs), which were defined as cardiovascular death, heart failure and recurrent MI. Results sST2 ranged from 20.57 to 98.96 ng/mL. High sST2 group had higher MACEs rate compared to low sST2 group (28.8% vs. 8.0%, P = 0.001). sST2 was positively correlated with age (r = 0.181, P = 0.027), SYNTAX score (r = 0.257, P = 0.002), high-sensitive C-reactive protein (hs-CRP) (r = 0.225, P = 0.006), B-type natriuretic peptide (BNP) (r = 0.225, P = 0.006) and negatively with left ventricle ejection fraction (LVEF) (r = -0.197, P = 0.016). After adjustment for clinical variables, sST2 level (OR 3.680, P = 0.015) and LVEF (OR 0.880, P < 0.001) remained independent predictors of 30-days MACEs. In receiver operating characteristic curve (ROC) analyses, the area under the curve (AUC) of sST2 for predicting 30-days MACEs was 0.755(P < 0.001). The AUC of sST2 combining hs-CRP and LVEF for prediction was 0.828(95%CI [0.743–0.912], P < 0.001). Conclusion sST2 level after primary PCI was an independent risk factor of MACEs in STEMI patients through 30 days follow-up.https://doi.org/10.1186/s12872-025-04488-zSoluble suppression of tumorigenicity-2Acute ST-elevation myocardial infarctionPrimary percutaneous coronary interventionMajor adverse cardiac events
spellingShingle Shan Huang
Lu-Jiao Yu
Guang-Feng Sun
Zi-Xin Zhang
Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
BMC Cardiovascular Disorders
Soluble suppression of tumorigenicity-2
Acute ST-elevation myocardial infarction
Primary percutaneous coronary intervention
Major adverse cardiac events
title Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
title_full Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
title_fullStr Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
title_full_unstemmed Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
title_short Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
title_sort short term predictive value of sst2 in patients with stemi following primary pci a prospective observational study
topic Soluble suppression of tumorigenicity-2
Acute ST-elevation myocardial infarction
Primary percutaneous coronary intervention
Major adverse cardiac events
url https://doi.org/10.1186/s12872-025-04488-z
work_keys_str_mv AT shanhuang shorttermpredictivevalueofsst2inpatientswithstemifollowingprimarypciaprospectiveobservationalstudy
AT lujiaoyu shorttermpredictivevalueofsst2inpatientswithstemifollowingprimarypciaprospectiveobservationalstudy
AT guangfengsun shorttermpredictivevalueofsst2inpatientswithstemifollowingprimarypciaprospectiveobservationalstudy
AT zixinzhang shorttermpredictivevalueofsst2inpatientswithstemifollowingprimarypciaprospectiveobservationalstudy